Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells

Romana A. Nowak, S. Mora, T. Diehl, A. R. Rhoades, Elizabeth A Stewart

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: To test the hypothesis that prolactin (PRL) acts as a mitogenic growth factor for human leiomyoma and myometrial cells. Methods: To test this hypothesis, we performed three different types of experiments. First, we assessed whether exogenous PRL acted as a mitogen for cultured uterine smooth muscle cells. Second, we examined the role of endogenous PRL by assessing the cell number after exposure of the cultures to a neutralizing antibody to PRL. Finally, we examined both fresh tissues and cultured cells for expression of the PRL receptor messenger ribonucleic acid using the techniques of reverse-transcriptase polymerase chain reaction and Southern blotting. Results: A significant suppression in cell number was seen after 5 days of culture for leiomyoma cells but not for myometrial cells after treatment with exogenous PRL. Both cell types showed a significant decrease in cell number after treatment with anti-PRL antibody. A 893-bp segment consistent with the cytoplasmic domain of the long form of the PRL receptor was amplified from both fresh and cultured tissues and con-firmed by Southern blotting and sequencing. Conclusions: PRL appears to be an autocrine or paracrine growth factor for both leiomyoma and myometrial cells. However, there are some differences between tissues in their sensitivity to this growth factor.

Original languageEnglish (US)
Pages (from-to)127-132
Number of pages6
JournalGynecologic and Obstetric Investigation
Volume48
Issue number2
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Leiomyoma
Prolactin
Intercellular Signaling Peptides and Proteins
Prolactin Receptors
Cell Count
Southern Blotting
Myometrium
Neutralizing Antibodies
Reverse Transcriptase Polymerase Chain Reaction
Mitogens
Smooth Muscle Myocytes
Anti-Idiotypic Antibodies
Cultured Cells
Cell Culture Techniques
RNA

Keywords

  • Leiomyomas
  • Mitogen
  • Myometrium
  • Prolactin
  • Prolactin receptor

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. / Nowak, Romana A.; Mora, S.; Diehl, T.; Rhoades, A. R.; Stewart, Elizabeth A.

In: Gynecologic and Obstetric Investigation, Vol. 48, No. 2, 1999, p. 127-132.

Research output: Contribution to journalArticle

@article{fbe263cff76b4d11b465b9dc8c476cd8,
title = "Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells",
abstract = "Objective: To test the hypothesis that prolactin (PRL) acts as a mitogenic growth factor for human leiomyoma and myometrial cells. Methods: To test this hypothesis, we performed three different types of experiments. First, we assessed whether exogenous PRL acted as a mitogen for cultured uterine smooth muscle cells. Second, we examined the role of endogenous PRL by assessing the cell number after exposure of the cultures to a neutralizing antibody to PRL. Finally, we examined both fresh tissues and cultured cells for expression of the PRL receptor messenger ribonucleic acid using the techniques of reverse-transcriptase polymerase chain reaction and Southern blotting. Results: A significant suppression in cell number was seen after 5 days of culture for leiomyoma cells but not for myometrial cells after treatment with exogenous PRL. Both cell types showed a significant decrease in cell number after treatment with anti-PRL antibody. A 893-bp segment consistent with the cytoplasmic domain of the long form of the PRL receptor was amplified from both fresh and cultured tissues and con-firmed by Southern blotting and sequencing. Conclusions: PRL appears to be an autocrine or paracrine growth factor for both leiomyoma and myometrial cells. However, there are some differences between tissues in their sensitivity to this growth factor.",
keywords = "Leiomyomas, Mitogen, Myometrium, Prolactin, Prolactin receptor",
author = "Nowak, {Romana A.} and S. Mora and T. Diehl and Rhoades, {A. R.} and Stewart, {Elizabeth A}",
year = "1999",
doi = "10.1159/000010154",
language = "English (US)",
volume = "48",
pages = "127--132",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells

AU - Nowak, Romana A.

AU - Mora, S.

AU - Diehl, T.

AU - Rhoades, A. R.

AU - Stewart, Elizabeth A

PY - 1999

Y1 - 1999

N2 - Objective: To test the hypothesis that prolactin (PRL) acts as a mitogenic growth factor for human leiomyoma and myometrial cells. Methods: To test this hypothesis, we performed three different types of experiments. First, we assessed whether exogenous PRL acted as a mitogen for cultured uterine smooth muscle cells. Second, we examined the role of endogenous PRL by assessing the cell number after exposure of the cultures to a neutralizing antibody to PRL. Finally, we examined both fresh tissues and cultured cells for expression of the PRL receptor messenger ribonucleic acid using the techniques of reverse-transcriptase polymerase chain reaction and Southern blotting. Results: A significant suppression in cell number was seen after 5 days of culture for leiomyoma cells but not for myometrial cells after treatment with exogenous PRL. Both cell types showed a significant decrease in cell number after treatment with anti-PRL antibody. A 893-bp segment consistent with the cytoplasmic domain of the long form of the PRL receptor was amplified from both fresh and cultured tissues and con-firmed by Southern blotting and sequencing. Conclusions: PRL appears to be an autocrine or paracrine growth factor for both leiomyoma and myometrial cells. However, there are some differences between tissues in their sensitivity to this growth factor.

AB - Objective: To test the hypothesis that prolactin (PRL) acts as a mitogenic growth factor for human leiomyoma and myometrial cells. Methods: To test this hypothesis, we performed three different types of experiments. First, we assessed whether exogenous PRL acted as a mitogen for cultured uterine smooth muscle cells. Second, we examined the role of endogenous PRL by assessing the cell number after exposure of the cultures to a neutralizing antibody to PRL. Finally, we examined both fresh tissues and cultured cells for expression of the PRL receptor messenger ribonucleic acid using the techniques of reverse-transcriptase polymerase chain reaction and Southern blotting. Results: A significant suppression in cell number was seen after 5 days of culture for leiomyoma cells but not for myometrial cells after treatment with exogenous PRL. Both cell types showed a significant decrease in cell number after treatment with anti-PRL antibody. A 893-bp segment consistent with the cytoplasmic domain of the long form of the PRL receptor was amplified from both fresh and cultured tissues and con-firmed by Southern blotting and sequencing. Conclusions: PRL appears to be an autocrine or paracrine growth factor for both leiomyoma and myometrial cells. However, there are some differences between tissues in their sensitivity to this growth factor.

KW - Leiomyomas

KW - Mitogen

KW - Myometrium

KW - Prolactin

KW - Prolactin receptor

UR - http://www.scopus.com/inward/record.url?scp=0032765873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032765873&partnerID=8YFLogxK

U2 - 10.1159/000010154

DO - 10.1159/000010154

M3 - Article

C2 - 10461005

AN - SCOPUS:0032765873

VL - 48

SP - 127

EP - 132

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 2

ER -